Stephen Baxter
Stock Analyst at Wells Fargo
(3.15)
# 1,132
Out of 5,147 analysts
254
Total ratings
47.24%
Success rate
0.49%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Maintains: Overweight | $1 → $1.5 | $0.59 | +154.54% | 11 | Feb 27, 2026 | |
| MDLN Medline | Maintains: Equal-Weight | $42 → $47 | $47.51 | -1.07% | 2 | Feb 27, 2026 | |
| MOH Molina Healthcare | Downgrades: Equal-Weight | $208 → $141 | $154.05 | -8.47% | 23 | Feb 20, 2026 | |
| HUM Humana | Maintains: Equal-Weight | $290 → $206 | $190.54 | +8.11% | 14 | Feb 18, 2026 | |
| CNC Centene | Maintains: Equal-Weight | $43 → $44 | $44.88 | -1.96% | 26 | Feb 18, 2026 | |
| COR Cencora | Maintains: Overweight | $405 → $429 | $372.14 | +15.28% | 6 | Feb 10, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $237 → $256 | $229.23 | +11.68% | 11 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Equal-Weight | $914 → $925 | $987.37 | -6.32% | 10 | Feb 5, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $400 → $370 | $293.27 | +26.16% | 16 | Jan 30, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $424 → $391 | $320.00 | +22.19% | 16 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $452 → $481 | $529.70 | -9.19% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $38 | $33.71 | +12.73% | 4 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $252 → $229 | $239.39 | -4.34% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3 → $2 | $3.46 | -42.20% | 12 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $39 → $43 | $41.43 | +3.79% | 8 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $259 → $235 | $206.10 | +14.02% | 17 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $14 → $11 | $13.64 | -19.35% | 13 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $102 | $79.90 | +27.66% | 16 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $354 → $300 | $289.82 | +3.51% | 10 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $5.26 | +185.17% | 3 | Apr 29, 2024 |
agilon health
Feb 27, 2026
Maintains: Overweight
Price Target: $1 → $1.5
Current: $0.59
Upside: +154.54%
Medline
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $42 → $47
Current: $47.51
Upside: -1.07%
Molina Healthcare
Feb 20, 2026
Downgrades: Equal-Weight
Price Target: $208 → $141
Current: $154.05
Upside: -8.47%
Humana
Feb 18, 2026
Maintains: Equal-Weight
Price Target: $290 → $206
Current: $190.54
Upside: +8.11%
Centene
Feb 18, 2026
Maintains: Equal-Weight
Price Target: $43 → $44
Current: $44.88
Upside: -1.96%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $405 → $429
Current: $372.14
Upside: +15.28%
Cardinal Health
Feb 10, 2026
Maintains: Overweight
Price Target: $237 → $256
Current: $229.23
Upside: +11.68%
McKesson
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $914 → $925
Current: $987.37
Upside: -6.32%
UnitedHealth Group
Jan 30, 2026
Maintains: Overweight
Price Target: $400 → $370
Current: $293.27
Upside: +26.16%
Elevance Health
Jan 30, 2026
Maintains: Overweight
Price Target: $424 → $391
Current: $320.00
Upside: +22.19%
Jan 30, 2026
Maintains: Equal-Weight
Price Target: $452 → $481
Current: $529.70
Upside: -9.19%
Jan 7, 2026
Maintains: Overweight
Price Target: $31 → $38
Current: $33.71
Upside: +12.73%
Jan 7, 2026
Maintains: Overweight
Price Target: $252 → $229
Current: $239.39
Upside: -4.34%
Jan 7, 2026
Maintains: Underweight
Price Target: $3 → $2
Current: $3.46
Upside: -42.20%
Jan 7, 2026
Maintains: Overweight
Price Target: $39 → $43
Current: $41.43
Upside: +3.79%
Jan 7, 2026
Downgrades: Equal-Weight
Price Target: $259 → $235
Current: $206.10
Upside: +14.02%
Nov 13, 2025
Maintains: Underweight
Price Target: $14 → $11
Current: $13.64
Upside: -19.35%
Nov 13, 2025
Maintains: Overweight
Price Target: $103 → $102
Current: $79.90
Upside: +27.66%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $354 → $300
Current: $289.82
Upside: +3.51%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $5.26
Upside: +185.17%